Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 83

1.

Carbapenem Nonsusceptible Klebsiella pneumoniae in Taiwan: Dissemination and Increasing Resistance of Carbapenemase Producers During 2012-2015.

Chiu SK, Ma L, Chan MC, Lin YT, Fung CP, Wu TL, Chuang YC, Lu PL, Wang JT, Lin JC, Yeh KM.

Sci Rep. 2018 May 31;8(1):8468. doi: 10.1038/s41598-018-26691-z.

2.

Risk factors for carbapenem-resistant K. pneumoniae bloodstream infection and predictors of mortality in Chinese paediatric patients.

Zhang Y, Guo LY, Song WQ, Wang Y, Dong F, Liu G.

BMC Infect Dis. 2018 May 31;18(1):248. doi: 10.1186/s12879-018-3160-3.

3.

A systematic review of the epidemiology of carbapenem-resistant Enterobacteriaceae in the United States.

Livorsi DJ, Chorazy ML, Schweizer ML, Balkenende EC, Blevins AE, Nair R, Samore MH, Nelson RE, Khader K, Perencevich EN.

Antimicrob Resist Infect Control. 2018 Apr 24;7:55. doi: 10.1186/s13756-018-0346-9. eCollection 2018.

4.

Iron Acquisition and Siderophore Release by Carbapenem-Resistant Sequence Type 258 Klebsiella pneumoniae.

Holden VI, Wright MS, Houle S, Collingwood A, Dozois CM, Adams MD, Bachman MA.

mSphere. 2018 Apr 18;3(2). pii: e00125-18. doi: 10.1128/mSphere.00125-18. Print 2018 Apr 25.

5.
6.

Carbapenem Resistance: A Review.

Codjoe FS, Donkor ES.

Med Sci (Basel). 2017 Dec 21;6(1). pii: E1. doi: 10.3390/medsci6010001. Review.

7.

Infection prevention and control measures and tools for the prevention of entry of carbapenem-resistant Enterobacteriaceae into healthcare settings: guidance from the European Centre for Disease Prevention and Control.

Magiorakos AP, Burns K, Rodríguez Baño J, Borg M, Daikos G, Dumpis U, Lucet JC, Moro ML, Tacconelli E, Simonsen GS, Szilágyi E, Voss A, Weber JT.

Antimicrob Resist Infect Control. 2017 Nov 15;6:113. doi: 10.1186/s13756-017-0259-z. eCollection 2017.

8.

Vaborbactam: Spectrum of Beta-Lactamase Inhibition and Impact of Resistance Mechanisms on Activity in Enterobacteriaceae.

Lomovskaya O, Sun D, Rubio-Aparicio D, Nelson K, Tsivkovski R, Griffith DC, Dudley MN.

Antimicrob Agents Chemother. 2017 Oct 24;61(11). pii: e01443-17. doi: 10.1128/AAC.01443-17. Print 2017 Nov.

9.

Evolving beta-lactamase epidemiology in Enterobacteriaceae from Italian nationwide surveillance, October 2013: KPC-carbapenemase spreading among outpatients.

Giani T, Antonelli A, Caltagirone M, Mauri C, Nicchi J, Arena F, Nucleo E, Bracco S, Pantosti A; AMCLI-CoSA survey participants, Luzzaro F, Pagani L, Rossolini GM.

Euro Surveill. 2017 Aug 3;22(31). pii: 30583. doi: 10.2807/1560-7917.ES.2017.22.31.30583. Erratum in: Euro Surveill. 2017 Aug 24;22(34):.

10.

Risk Factors for Carbapenem-Resistant Klebsiella pneumoniae Infection: A Meta-Analysis.

Liu P, Li X, Luo M, Xu X, Su K, Chen S, Qing Y, Li Y, Qiu J.

Microb Drug Resist. 2018 Mar;24(2):190-198. doi: 10.1089/mdr.2017.0061. Epub 2017 Jul 27.

PMID:
28749714
11.

Bacteria antibiotic resistance: New challenges and opportunities for implant-associated orthopedic infections.

Li B, Webster TJ.

J Orthop Res. 2018 Jan;36(1):22-32. doi: 10.1002/jor.23656. Epub 2017 Aug 11.

12.

Molecular Epidemiology and Risk Factors of Carbapenem-Resistant Klebsiella pneumoniae Infections in Eastern China.

Zheng B, Dai Y, Liu Y, Shi W, Dai E, Han Y, Zheng D, Yu Y, Li M.

Front Microbiol. 2017 Jun 13;8:1061. doi: 10.3389/fmicb.2017.01061. eCollection 2017.

13.

Carbapenemase-Producing Enterobacteriaceae Isolates from Edo State, Nigeria.

Jesumirhewe C, Springer B, Lepuschitz S, Allerberger F, Ruppitsch W.

Antimicrob Agents Chemother. 2017 Jul 25;61(8). pii: e00255-17. doi: 10.1128/AAC.00255-17. Print 2017 Aug. No abstract available.

14.

Differential Th17 response induced by the two clades of the pandemic ST258 Klebsiella pneumoniae clonal lineages producing KPC-type carbapenemase.

Clemente AM, Castronovo G, Antonelli A, D'Andrea MM, Tanturli M, Perissi E, Paccosi S, Parenti A, Cozzolino F, Rossolini GM, Torcia MG.

PLoS One. 2017 Jun 6;12(6):e0178847. doi: 10.1371/journal.pone.0178847. eCollection 2017.

15.

Clonal replacement of epidemic KPC-producing Klebsiella pneumoniae in a hospital in China.

Liang Y, Yin X, Zeng L, Chen S.

BMC Infect Dis. 2017 May 23;17(1):363. doi: 10.1186/s12879-017-2467-9.

16.

Prevalence of Acquired Carbapenemase Genes in Klebsiella Pneumoniae by Multiplex PCR in Isfahan.

Khorvash F, Yazdani MR, Soudi AA, Shabani S, Tavahen N.

Adv Biomed Res. 2017 Apr 17;6:41. doi: 10.4103/2277-9175.204594. eCollection 2017.

17.

High burden of Carbapenem-resistant Enterobacteriaceae (CRE) fecal carriage at a teaching hospital: cost-effectiveness of screening in low-resource setting.

Zaidah AR, Mohammad NI, Suraiya S, Harun A.

Antimicrob Resist Infect Control. 2017 May 2;6:42. doi: 10.1186/s13756-017-0200-5. eCollection 2017.

18.

Characteristics of carbapenemase-producing Klebsiella pneumoniae as a cause of neonatal infection in Shandong, China.

Jin Y, Song X, Liu Y, Wang Y, Zhang B, Fan H, Shao C.

Exp Ther Med. 2017 Mar;13(3):1117-1126. doi: 10.3892/etm.2017.4070. Epub 2017 Jan 20.

19.

Retrospective analysis of fosfomycin combinational therapy for sepsis caused by carbapenem-resistant Klebsiella pneumoniae.

Liao Y, Hu GH, Xu YF, Che JP, Luo M, Zhang HM, Peng B, Yao XD, Zheng JH, Liu M.

Exp Ther Med. 2017 Mar;13(3):1003-1010. doi: 10.3892/etm.2017.4046. Epub 2017 Jan 16.

20.

Systematic review and meta-analysis of mortality of patients infected with carbapenem-resistant Klebsiella pneumoniae.

Xu L, Sun X, Ma X.

Ann Clin Microbiol Antimicrob. 2017 Mar 29;16(1):18. doi: 10.1186/s12941-017-0191-3. Review.

Supplemental Content

Support Center